Truist Financial Has Lowered Expectations for OrthoPediatrics (NASDAQ:KIDS) Stock Price

OrthoPediatrics (NASDAQ:KIDS) had its price objective decreased by analysts at Truist Financial from $28.00 to $25.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “hold” rating on the stock. Truist Financial’s target price points to a potential upside of 10.67% from the stock’s previous close.

KIDS has been the topic of a number of other reports. JMP Securities reaffirmed a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Friday, September 13th. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Friday, November 8th.

OrthoPediatrics Stock Up 1.2 %

Shares of OrthoPediatrics stock opened at $22.59 on Wednesday. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. The company has a market cap of $547.04 million, a P/E ratio of -18.37 and a beta of 1.14. The firm’s 50 day moving average price is $25.30 and its 200-day moving average price is $28.22. OrthoPediatrics has a 52-week low of $21.02 and a 52-week high of $36.23.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Barclays PLC raised its stake in OrthoPediatrics by 319.3% in the 3rd quarter. Barclays PLC now owns 25,298 shares of the company’s stock worth $686,000 after acquiring an additional 19,264 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of OrthoPediatrics by 2.1% in the third quarter. Geode Capital Management LLC now owns 391,492 shares of the company’s stock worth $10,615,000 after purchasing an additional 7,972 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of OrthoPediatrics by 16.2% in the third quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock worth $23,944,000 after purchasing an additional 122,846 shares during the last quarter. State Street Corp lifted its holdings in shares of OrthoPediatrics by 1.0% during the third quarter. State Street Corp now owns 417,898 shares of the company’s stock worth $11,329,000 after purchasing an additional 4,236 shares during the period. Finally, Quarry LP purchased a new stake in OrthoPediatrics in the third quarter valued at approximately $25,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.